Abstract:Background Excessive dietary sodium intake is an independent risk factor for hypertension and cardiovascular disease (CVD). Despite the large body of evidence concerning the effects of dietary interventions on blood pressure (BP) and CVD outcomes, trials have often reported low adherence to decreased sodium intake, likely due in part to heterogeneous BP responses. To address the challenges, recent clinical findings suggested a precise and personalized dietary approach that seeks to deliver more preventive and practical dietary advice than the “one-size-fits-all” guidelines and weighs the personal risk of developing specific diseases. Objective The purpose of this pilot randomized controlled trial was to test the feasibility and preliminary efficacy of integrating the use of mobile technology and metabolomics with a low-sodium diet intervention in patients with hypertension to develop personalized low-sodium diet programs. Additionally, the study will examine the associations of urine metabolites with urinary sodium levels and BP control based on the hypothesis that targeted urine metabolites. In this report, we describe the design and protocol of the pilot trial. Methods A total of 40 patients with hypertension will be randomly assigned to either a 8-week low-sodium diet group (n=20) or a standard care group (n=20). Each week, intervention participants went through individual sessions with an interventionist via videoconferencing to discuss low-sodium diet regimens, patients’ food choices, and BP tracks on mobile apps. The control group followed their usual care for hypertension management. All participants in both groups monitored diet and BP using mobile apps for 8 weeks. A 24-hour urinary sodium excretion for the estimation of dietary sodium intake, systolic, and diastolic BPs were measured at the baseline and at 8 weeks. The primary outcomes of this study include the feasibility of conducting a randomized controlled trial (RCT) by reporting recruitment, retention, and completion statistics. The preliminary effects of intervention will be tested by a generalized estimating equation model. Results This pilot RCT study was approved by the institutional review board at the University of Texas Health San Antonio in January 2021. The first participant was enrolled in April 2021, and currently, 26 participants were enrolled. All data collection is expected to conclude by March 2023, with data analysis and study results ready for reporting by December 2023. Findings from this pilot RCT will further guide the team in planning a future large-scale study. Conclusions The findings of this proposed study will establish a comprehensive knowledge base for future research and development of personalized dietary interventions to promote adherence to dietary strategies and self-management of chronic disease using the Precision Health approach for millions of Americans who are struggling with uncontrolled hypertension. Trial Registration ClinicalTrials.gov NCT04764253; https://clinicaltrials.gov/ct2/show/NCT04764253 International Registered Report Identifier (IRRID) DERR1-10.2196/39058

Addressing Inpatient Hyponatremia Through Targeted Automatic E-consults: A Pilot Randomized Trial

Hyponatremia - Treatment standard 2024

Hyponatremia in the neurocritical care patient: An approach based on current evidence

Nurse-led diuretic titration via a point-of-care urinary sodium sensor in patients with acute decompensated heart failure (EASY-HF): A single-centre, randomized, open-label study

Point of care cardiac ultrasound in the management of hyponatremia: an enhancement to physical examination

A Reassessment of Sodium Correction Rates and Hospital Length of Stay Accounting for Admission Diagnosis

Predictors of outcome in hospitalized patients with severe hyponatremia.

Point‐of‐care ultrasound is a useful adjunct tool to a clinician's assessment in the evaluation of severe hyponatraemia

Clinical factors associated with hyponatremia correction during treatment with oral Urea

The utility of urine sodium–guided diuresis during acute decompensated heart failure

Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremia

Low-chloride versus high-chloride hypertonic solution for the treatment of subarachnoid hemorrhage-related complications (The ACETatE trial): study protocol for a pilot randomized controlled trial

Remote Monitoring Titration Clinic To Implement Guideline-directed Medical Therapy For Heart Failure Patients With Reduced Ejection Fraction: A Pilot Intervention Study

Electronic Health Record Alert With Heart Failure Risk and Sodium Glucose Cotransporter 2 Inhibitor Prescriptions in Diabetes: A Randomized Clinical Trial

Safety and efficacy of proactive versus reactive administration of desmopressin in severe symptomatic hyponatremia: a randomized controlled trial

Examining the Individual Response to a Low-Sodium Diet in Patients with Hypertension: Protocol for a Pilot Randomized Controlled Trial

Sterile water and regional citrate anticoagulation: A simple CRRT strategy for safe correction of severe hyponatraemia

Hyponatremia in the emergency department: an overview of diagnostic and therapeutic approach

Zero Diffusive Sodium Balance in Hemodialysis Provided by an Algorithm‐Based Electrolyte Balancing Controller: A Proof of Principle Clinical Study

Timing of Repeat Plasma Sodium As a Risk Factor for Eventual Sodium Overcorrection in Patients with Severe Hyponatremia